Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (5) , 883-893
- https://doi.org/10.1016/s0149-2918(97)80042-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosisNeurology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisJournal of Neuroimmunology, 1996
- Management of patients receiving interferon beta-1b for multiple sclerosisNeurology, 1996
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1bNew England Journal of Medicine, 1995
- MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSISThe Lancet, 1986
- Intrathecal Interferon in the Treatment of Multiple SclerosisArchives of Neurology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983